文献速递烧伤创面修复显微修复重建

皮肤同种异体移植在烧伤治疗中的免疫学效应:对未来血管化复合组织移植的影响

Immunological Effect of Skin Allograft in Burn Treatment: Impact on Future Vascularized Composite Allotransplantation.
PubMed 文献 · J Burn Care Res · 2017-01-01

该研究检测了9例接受同种异体皮移植的成年未输血未移植烧伤患者的计算群体反应性抗体(cPRA),并与92例成年未移植男性对照比较。结果显示研究组cPRA显著高于对照组(26±31% vs 8±17%,P=.0075),急性烧伤期cPRA低于伤后数月至数年(6±12% vs 42±33%,P=.08)。提示皮肤同种异体移植增加免疫致敏,可能限制未来血管化复合组织移植的应用。

要点

  • 接受同种异体皮移植的烧伤患者cPRA显著高于未致敏对照(P=.0075)。
  • 急性烧伤期cPRA检测值低于伤后数月至数年(P=.08)。
  • 免疫致敏增加可能限制烧伤患者接受血管化复合组织移植。

核心结论

  • 接受皮肤同种异体移植的烧伤患者较未致敏对照表现出更高的免疫致敏。
  • 急性烧伤期人类白细胞抗原抗体检测水平低于伤后数月至数年。
  • 致敏增加可能最终限制烧伤患者接受血管化复合组织移植的候选资格或降低手术成功率。

研究设计与样本

  • 研究纳入9例接受同种异体皮移植的成年、未输血、未移植烧伤患者,每例平均接受3.55±1.24个不同供体的同种异体皮。
  • 第1组为急性烧伤期检测的患者,第2组为伤后数月至数年检测的不同患者。
  • 对照数据来自92例成年未移植男性,评估每例患者的计算群体反应性抗体(cPRA)百分比。

主要发现

  • 第1组cPRA低于第2组(6±12% vs 42±33%,P=.08)。
  • 研究组cPRA显著高于对照组(26±31% vs 8±17%,P=.0075)。

临床怎么用

  • 烧伤患者接受同种异体皮移植后应关注人类白细胞抗原致敏状态,尤其伤后数月至数年。
  • 对考虑未来血管化复合组织移植的烧伤患者,需评估同种异体皮移植带来的致敏风险。

局限性

  • 研究样本量小(9例烧伤患者),组间比较P=.08未达统计学显著性。
  • 对照组为92例成年未移植男性,与研究组特征不完全匹配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Skin allografts are the gold standard in temporary burn wound coverage, but allografts are hypothesized to place a high antigenic load on recipients. This project aims to determine the degree of human leukocyte antigen sensitization in burn patients treated with allografts. Serum was obtained from nine adult, nontransfused, and nontransplanted burn patients treated with allografts. Group 1 included patients tested in the acute burn period, while group 2 included different patients tested months to years after injury. A calculated panel reactive antibody (cPRA) percent was assessed for each patient, and data for a control group of 92 adult nontransplanted males were used for comparison. Each patient received allografts from an average 3.55 ± 1.24 different donors. cPRA in group 1 was lower than in group 2 (6 ± 12% vs 42 ± 33%, P = .08). cPRA in the study group was significantly higher than in the control group (26 ± 31% vs 8 ± 17%, P = .0075). Burn patients who receive skin allograft demonstrate increased immunological sensitization compared with unsensitized controls. Detection of human leukocyte antigen antibody is lower in the acute burn period than months to years after injury. Increased sensitization may ultimately limit burn patients' candidacy for vascularized composite allotransplantation or decrease success of these procedures.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Garza RM, Press BH, Tyan DB, et al. Immunological Effect of Skin Allograft in Burn Treatment: Impact on Future Vascularized Composite Allotransplantation. J Burn Care Res. 2017. PMID: 27801681. doi:10.1097/BCR.0000000000000458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。